{
  "2SE.SG": {
    "city": "Gent",
    "country": "Belgium",
    "currency": "EUR",
    "exchange": "STU",
    "industry": "Medical Devices",
    "long_name": "Sequana Medical NV",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Sequana Medical NV Actions Nom.",
    "state": null,
    "summary": "Sequana Medical NV, a commercial stage medical device company, focuses on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure in Switzerland, Germany, and internationally. Its products include alfapump, a treatment solution for the management of liver refractory ascites and malignant ascites; and alfapump DSR, a fully implanted system for direct sodium removal therapy in patients with volume overload due to heart failure. The company was founded in 2006 and is headquartered in Ghent, Belgium.",
    "website": "http://www.sequanamedical.com",
    "zipcode": "9052"
  },
  "IBAB.BR": {
    "city": "Louvain-la-Neuve",
    "country": "Belgium",
    "currency": "EUR",
    "exchange": "BRU",
    "industry": "Medical Devices",
    "long_name": "Ion Beam Applications SA",
    "market": "be_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "IBA",
    "state": null,
    "summary": "Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.",
    "website": "http://www.iba-worldwide.com",
    "zipcode": "1348"
  },
  "IOB.F": {
    "city": "Louvain-la-Neuve",
    "country": "Belgium",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Ion Beam Applications SA",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "ION BEAM APPLICATIONS SA",
    "state": null,
    "summary": "Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.",
    "website": "http://www.iba-worldwide.com",
    "zipcode": "1348"
  },
  "IOBCF": {
    "city": "Louvain-la-Neuve",
    "country": "Belgium",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Ion Beam Applications SA",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "IBA(ION BEAM APPLICATIONS)",
    "state": null,
    "summary": "Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.",
    "website": "http://www.iba-worldwide.com",
    "zipcode": "1348"
  },
  "SEQUA.BR": {
    "city": "Gent",
    "country": "Belgium",
    "currency": "EUR",
    "exchange": "BRU",
    "industry": "Medical Devices",
    "long_name": "Sequana Medical NV",
    "market": "be_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "SEQUANA MEDICAL",
    "state": null,
    "summary": "Sequana Medical NV, a commercial stage medical device company, focuses on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure in Switzerland, Germany, and internationally. Its products include alfapump, a treatment solution for the management of liver refractory ascites and malignant ascites; and alfapump DSR, a fully implanted system for direct sodium removal therapy in patients with volume overload due to heart failure. The company was founded in 2006 and is headquartered in Ghent, Belgium.",
    "website": "http://www.sequanamedical.com",
    "zipcode": "9052"
  }
}
